NO20006547D0 - Salter av paroxetine - Google Patents
Salter av paroxetineInfo
- Publication number
- NO20006547D0 NO20006547D0 NO20006547A NO20006547A NO20006547D0 NO 20006547 D0 NO20006547 D0 NO 20006547D0 NO 20006547 A NO20006547 A NO 20006547A NO 20006547 A NO20006547 A NO 20006547A NO 20006547 D0 NO20006547 D0 NO 20006547D0
- Authority
- NO
- Norway
- Prior art keywords
- paroxetine
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9814316.7A GB9814316D0 (en) | 1998-07-02 | 1998-07-02 | Novel compounds |
| PCT/EP1999/004543 WO2000001692A1 (en) | 1998-07-02 | 1999-06-30 | Salts of paroxetine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20006547D0 true NO20006547D0 (no) | 2000-12-21 |
| NO20006547L NO20006547L (no) | 2001-02-12 |
Family
ID=10834803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20006547A NO20006547L (no) | 1998-07-02 | 2000-12-21 | Salter av paroxetine |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1091958A1 (no) |
| JP (1) | JP2002519421A (no) |
| KR (1) | KR20010053337A (no) |
| CN (1) | CN1314906A (no) |
| AP (1) | AP2000002017A0 (no) |
| AU (2) | AU4903999A (no) |
| BG (1) | BG105204A (no) |
| BR (1) | BR9911679A (no) |
| CA (1) | CA2336470A1 (no) |
| CZ (1) | CZ20004923A3 (no) |
| EA (1) | EA200100098A1 (no) |
| GB (1) | GB9814316D0 (no) |
| HU (1) | HUP0103712A3 (no) |
| ID (1) | ID27766A (no) |
| IL (1) | IL140385A0 (no) |
| NO (1) | NO20006547L (no) |
| PL (1) | PL345365A1 (no) |
| SK (1) | SK20242000A3 (no) |
| TR (1) | TR200100055T2 (no) |
| WO (1) | WO2000001692A1 (no) |
| ZA (2) | ZA992899B (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1534305B9 (en) | 2003-05-07 | 2007-03-07 | Osteologix A/S | Treating cartilage / bone conditions with water-soluble strontium salts |
| WO2005082385A1 (en) | 2004-02-26 | 2005-09-09 | Osteologix A/S | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
| EP2266584B1 (en) | 2003-05-07 | 2012-09-05 | Osteologix A/S | Composition with strontium and vitamin D for the prophylaxis and/or treatment of cartilage and/or bone conditions |
| AU2005240257B2 (en) | 2004-05-06 | 2011-11-24 | Osteologix A/S | High yield and rapid syntheses methods for producing metallo-organic salts |
| KR100672184B1 (ko) | 2004-09-21 | 2007-01-19 | 주식회사종근당 | 파록세틴의 콜린산 또는 콜린산 유도체 염 |
| CA2672267C (en) | 2006-07-27 | 2016-05-31 | Emisphere Technologies, Inc. | Arylsulfanyl compounds and compositions for delivering active agents |
| CN109212055B (zh) * | 2018-08-19 | 2021-05-07 | 丁立平 | 一种测定饮用水中四种痕量单卤代苯乙酸的气相色谱-质谱联用法 |
| CN109342633B (zh) * | 2018-11-27 | 2020-10-02 | 北京市化工职业病防治院 | 尿液中苯、甲苯和二甲苯代谢物的检测方法 |
| CN111337460B (zh) * | 2018-12-18 | 2021-09-17 | 中国科学院大连化学物理研究所 | 一种高稳定性Halo-tag探针及其合成和生物应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
| EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
| CA2206592A1 (en) * | 1996-05-30 | 1997-11-30 | Shu-Zhong Wang | Method of producing amorphous paroxetine hydrochloride |
| HU221921B1 (hu) * | 1996-07-08 | 2003-02-28 | Richter Gedeon Vegyészeti Gyár Rt. | N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására |
| CA2293247C (en) * | 1997-06-10 | 2005-04-12 | Synthon B.V. | 4-phenylpiperidine compounds |
| IL137684A0 (en) * | 1998-02-06 | 2001-10-31 | Smithkline Beechmam Plc | Salts of paroxetine |
-
1998
- 1998-07-02 GB GBGB9814316.7A patent/GB9814316D0/en not_active Ceased
-
1999
- 1999-04-23 ZA ZA9902899A patent/ZA992899B/xx unknown
- 1999-06-30 EA EA200100098A patent/EA200100098A1/ru unknown
- 1999-06-30 KR KR1020007015100A patent/KR20010053337A/ko not_active Application Discontinuation
- 1999-06-30 CN CN99810197A patent/CN1314906A/zh active Pending
- 1999-06-30 PL PL99345365A patent/PL345365A1/xx not_active Application Discontinuation
- 1999-06-30 WO PCT/EP1999/004543 patent/WO2000001692A1/en not_active Application Discontinuation
- 1999-06-30 CA CA002336470A patent/CA2336470A1/en not_active Abandoned
- 1999-06-30 AU AU49039/99A patent/AU4903999A/en not_active Abandoned
- 1999-06-30 ID IDW20010252A patent/ID27766A/id unknown
- 1999-06-30 SK SK2024-2000A patent/SK20242000A3/sk unknown
- 1999-06-30 AP APAP/P/2000/002017A patent/AP2000002017A0/en unknown
- 1999-06-30 JP JP2000558095A patent/JP2002519421A/ja active Pending
- 1999-06-30 EP EP99932772A patent/EP1091958A1/en not_active Withdrawn
- 1999-06-30 IL IL14038599A patent/IL140385A0/xx unknown
- 1999-06-30 CZ CZ20004923A patent/CZ20004923A3/cs unknown
- 1999-06-30 BR BR9911679-0A patent/BR9911679A/pt not_active Application Discontinuation
- 1999-06-30 TR TR2001/00055T patent/TR200100055T2/xx unknown
- 1999-06-30 HU HU0103712A patent/HUP0103712A3/hu unknown
-
2000
- 2000-12-21 NO NO20006547A patent/NO20006547L/no not_active Application Discontinuation
-
2001
- 2001-01-02 ZA ZA200100020A patent/ZA200100020B/en unknown
- 2001-01-31 BG BG105204A patent/BG105204A/xx unknown
- 2001-07-11 AU AU2002100370A patent/AU2002100370A4/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000001692A1 (en) | 2000-01-13 |
| AP2000002017A0 (en) | 2000-12-31 |
| BR9911679A (pt) | 2002-01-29 |
| TR200100055T2 (tr) | 2001-07-23 |
| ZA992899B (en) | 2000-03-29 |
| EA200100098A1 (ru) | 2001-08-27 |
| BG105204A (en) | 2001-11-30 |
| EP1091958A1 (en) | 2001-04-18 |
| PL345365A1 (en) | 2001-12-17 |
| CN1314906A (zh) | 2001-09-26 |
| SK20242000A3 (sk) | 2001-07-10 |
| CA2336470A1 (en) | 2000-01-13 |
| ID27766A (id) | 2001-04-26 |
| AU4903999A (en) | 2000-01-24 |
| HUP0103712A2 (hu) | 2002-05-29 |
| IL140385A0 (en) | 2002-02-10 |
| GB9814316D0 (en) | 1998-09-02 |
| AU2002100370A4 (en) | 2002-06-06 |
| NO20006547L (no) | 2001-02-12 |
| KR20010053337A (ko) | 2001-06-25 |
| HUP0103712A3 (en) | 2002-09-30 |
| ZA200100020B (en) | 2002-03-25 |
| CZ20004923A3 (cs) | 2001-08-15 |
| JP2002519421A (ja) | 2002-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60000003T2 (de) | Paroxetinmethansulfonat | |
| CY2014027I2 (el) | Xρηση διαλκυλο φουμαρικων εστερων | |
| ID27092A (id) | Pembuatan ftalat anhidrida | |
| IS2277B (is) | Meðferðarlegar bíarýl afleiður | |
| EE200300007A (et) | Heterotsüklilised tetrahüdropüridino- või piperidinoderivaadid | |
| NO20011083L (no) | Krystallinske former av EtOC2--CH2-(R)Cgl-Aze-Pab-OH | |
| NO20003960D0 (no) | Salter av paroksetin | |
| PT1246817E (pt) | Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetra-hidropiridilo | |
| NO20006547D0 (no) | Salter av paroxetine | |
| NO20016151D0 (no) | Fremstilling av substituerte piperidin-4-oner | |
| ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
| DE29822563U1 (de) | Implantat | |
| NO20010553D0 (no) | Krystallinske former av osanetant | |
| DE50009938D1 (de) | Verwendung von nanoskaligen wachsen | |
| EE200100381A (et) | Morfolinobensamiidi uued soolad | |
| EE200100017A (et) | N-tert-butüülhüdroksüülamiini uued soolad | |
| FR2802852B3 (fr) | Production d'elements figures | |
| PT1178984E (pt) | Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano | |
| PT1175417E (pt) | Compostos substituidos de benzolactamas | |
| NO20004583D0 (no) | Krystallinsk form av paroxetine | |
| FI981803A0 (fi) | Menetelmä saostumien muodostumisen estämiseksi | |
| NO20016030L (no) | Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin | |
| PT1232141E (pt) | Eteres de o-desmetil-venlafaxina | |
| NO20005683D0 (no) | Ny formulering inneholdende paroxetin | |
| NO20013453L (no) | Fremgangsmate for fremstilling av salter av cyanobenzylaminer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |